Telehealth Follow-Up After Hospital Discharge: Lessons From HM17
Leaving hospital is often treated as the end of an episode of care, yet the first few days at home can be clinically fragile. Patients may be uncertain about medicines, follow-up appointments, wound care, diet, mobility or warning signs. A short telephone or video review can identify these problems before they become an emergency department presentation or an avoidable readmission.
The HM17 pilot program examined how telehealth could support this transition. Presented in the hospital medicine setting, it focused on timely contact, practical problem-solving and coordination between hospital and community clinicians. Its lessons remain relevant to Australian hospitals exploring virtual wards, transitional care and digitally supported discharge follow-up.
Why The Post-Discharge Window Matters
Many post-hospital complications begin with small misunderstandings. A patient may continue a medicine that was stopped, fail to collect a prescription, misread fluid restrictions or assume that worsening breathlessness is part of normal recovery. These issues are particularly important after treatment for heart failure, pneumonia, chronic obstructive pulmonary disease, infection or complex surgery.
Traditional follow-up can be slow. A general practitioner appointment may not be available for several days, while a specialist clinic may be scheduled weeks later. Hospital staff may have limited visibility once the patient leaves. Telehealth creates a bridge between discharge and the next formal review, giving a hospitalist or trained nurse an opportunity to check symptoms, medicines and care arrangements.
For Australian services, the model also responds to geography. A patient in regional New South Wales, far north Queensland or rural Western Australia may face a long drive for a brief review. A well-designed telephone service can reduce travel, while video may help clinicians assess mobility, breathing effort or home equipment when the internet connection is reliable.
What The HM17 Pilot Tested
The HM17 approach treated telehealth as a structured clinical encounter rather than a courtesy call. Patients were contacted soon after discharge, with the timing adjusted to risk. The review commonly covered symptoms, medication access, pending tests, follow-up appointments, self-management instructions and the patient’s confidence about coping at home.
The pilot also highlighted the value of a defined escalation pathway. A nurse or pharmacist could resolve a straightforward question, while a hospitalist reviewed concerning symptoms or an unclear discharge plan. The goal was not to replace primary care. It was to close the information gap between the inpatient team and the clinicians responsible for ongoing care.
The broader conference learning archive placed this work within hospital medicine’s interest in safer transitions, quality improvement and practical innovation. That context matters because virtual follow-up works best when it is connected to discharge planning, documentation and multidisciplinary communication.
Results That Mattered Clinically
The strongest result was improved contact during the vulnerable early recovery period. Patients were more likely to describe problems that had not appeared in the discharge summary, including dizziness, worsening pain, confusion about doses and difficulty obtaining medicines. Early recognition allowed the care team to arrange a prescription change, outpatient appointment, community nursing visit or urgent assessment.
The pilot also demonstrated that telehealth could improve patient understanding. Patients had a second opportunity to explain the plan in their own words, and clinicians could correct misunderstandings without waiting for a readmission. This teach-back approach is especially useful when discharge information is dense or when several clinicians have contributed to the treatment plan.
These outcomes should be interpreted carefully. A pilot can show feasibility and reveal safety signals, but it may not prove that telehealth alone reduces mortality or readmissions. Results depend on which patients are selected, how quickly calls are made, whether clinicians have access to records and what happens after an issue is identified. A failed call is not a neutral outcome if no alternative contact method exists.
Medication Safety Needs A Deliberate Process
Medication reconciliation was one of the most valuable applications of post-discharge telehealth. The reviewer can ask the patient to show or read out every medicine at home, compare that list with the discharge summary and identify duplication, omission or an incorrect dose. This is particularly important when a patient has multiple prescribers or uses medicines supplied by different pharmacies.
A pharmacist-led component can strengthen the process. Pharmacists are well placed to check dose changes, anticoagulants, insulin, opioids, antibiotics and medicines affected by renal function. Hospitalists can then address clinical uncertainty, while the general practitioner receives a clear update. Practical guidance on pharmacist collaborative rounding is relevant because reliable medication review begins with clear role allocation before discharge.
Australian implementation should account for local medication pathways. Patients may use community pharmacies, dose administration aids, residential aged-care services or medicines subsidised through the Pharmaceutical Benefits Scheme. A telehealth reviewer should confirm whether the patient has actually collected the prescription, not simply whether it was electronically sent.
Designing An Equitable Australian Service
Access cannot be assumed. Some older patients have hearing impairment, limited digital confidence or no suitable device. Others live in homes with weak broadband or rely on prepaid mobile data. The service should therefore offer telephone as a genuine alternative to video, provide interpreter access and allow a family member or carer to participate with consent.
Privacy and digital records also require attention. Clinicians should document the encounter in the hospital record and share relevant information with the patient’s general practitioner. Where appropriate, information can be aligned with My Health Record, but a digital upload does not replace direct communication. Patients should know who is calling, why the review is occurring and how urgent concerns will be managed.
Cultural safety is equally important. Services working with Aboriginal and Torres Strait Islander patients should involve local Aboriginal health workers and avoid assuming that a hospital-centred model fits every community. In cities such as Melbourne and Sydney, multilingual support may be central; in remote areas, local primary health networks and community-controlled services may be the essential partners.
Measuring Value Beyond Readmissions
A credible evaluation should combine clinical, operational and patient-reported measures. Readmission is important, yet it is influenced by housing, disease severity, primary care access and social support. A telehealth program may deliver substantial value by preventing medication harm or identifying deterioration even when overall readmission rates remain unchanged.
Useful measures include the proportion of eligible patients reached, time from discharge to first contact, completed medication reconciliation, urgent escalations, emergency department presentations and unplanned readmissions. Teams can also track whether discharge summaries reached general practitioners and whether patients understood their follow-up plan.
| Area | Practical measure | What a positive result suggests |
|---|---|---|
| Reach | Percentage of eligible patients contacted | The service is accessible and operational |
| Safety | Medication discrepancies identified and resolved | The review is finding clinically meaningful problems |
| Timeliness | Hours or days from discharge to contact | High-risk patients are being reviewed promptly |
| Experience | Patient confidence and ease of access | The model is acceptable to patients and carers |
| Outcomes | Emergency visits and readmissions | The service may be influencing avoidable deterioration |
| Equity | Completion rates by age, language, location and digital access | Benefits are not limited to digitally confident patients |
Cost should be assessed with equal care. Savings may arise from avoided travel, reduced emergency presentations or more efficient specialist review, while expenses include staff time, interpreter services, software, training and escalation capacity. A low-cost call that produces no response pathway is unlikely to deliver durable value.
Building A Scalable Follow-Up Pathway
The HM17 findings support a tiered model. Before discharge, staff identify patients who need early contact, record preferred communication methods and confirm the responsible clinician. Within the agreed timeframe, a nurse, pharmacist or hospitalist completes a structured review. Issues are categorised as education, medication, primary care coordination or urgent clinical escalation.
The pathway should fit existing Australian services rather than create a parallel system. A metropolitan hospital may link the program with a virtual ward, hospital-in-the-home team or specialist outpatient clinic. A regional hospital may coordinate with a local GP, Aboriginal medical service or community nurse. The technology is secondary to the reliability of the workflow.
Training should cover clinical red flags, privacy, documentation, interpreter use and communication with carers. Simulation can help staff practise a call in which a patient reports increasing breathlessness, has not obtained a new medicine or cannot attend an appointment. Clear protocols prevent staff from treating every concern as an emergency while ensuring genuine deterioration is not minimised.
The practical next step is to select one high-risk discharge group, appoint a nurse-pharmacist-hospitalist team and audit the first 30 follow-up contacts within seven days of discharge.
-
Re-energize and focus your practice with the latest research, best practices and newest innovations in the field that can immediately be applied to improving patient care.
-
Learn from the “best of the best,” including nationally renowned leaders in the field of hospital medicine.
-
Connect and collaborate with a vibrant community of hospital medicine professionals.